Home > Financial Ratios > AARTI DRUGS

AARTI DRUGS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 2.47-5.634.24-9.38-22.70

What is the latest Core EBITDA Growth ratio of AARTI DRUGS ?

The latest Core EBITDA Growth ratio of AARTI DRUGS is 2.47 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar20262.47
Mar2025-5.63
Mar20244.24
Mar2023-9.38
Mar2022-22.70

How is Core EBITDA Growth of AARTI DRUGS Trending?

Years Core EBITDA Growth % Change
Mar2026 2.47
Positive
Mar2025 -5.63
Negative
Mar2024 4.24
Positive
Mar2023 -9.38
Negative
Mar2022 -22.7 -

Other Financial Ratios of AARTI DRUGS


Compare Core EBITDA Growth ratio of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹4,250.9 Cr 4% 10.3% -5.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹425,150.0 Cr 0.8% -2.1% 4.8% Stock Analytics
DIVIS LABORATORIES ₹266,265.0 Cr 4.9% 7.9% 54.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,300.0 Cr 1.6% -2.7% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹114,351.0 Cr 2.6% 14.2% 3.9% Stock Analytics
CIPLA ₹112,474.0 Cr 2.4% 3.4% -12% Stock Analytics


AARTI DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

4%

10.3%

-5.7%

SENSEX

4.5%

6.1%

-9.3%


You may also like the below Video Courses